Mersana Therapeutics Ownership | Who Owns Mersana Therapeutics?


OverviewForecastRevenueFinancialsChartTranscripts

Mersana Therapeutics Ownership Summary


Mersana Therapeutics is owned by 82.62% institutional investors, 1.51% insiders, and 15.87% retail investors. Nextech invest is the largest institutional shareholder, holding 9.83% of MRSN shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.78% of its assets in Mersana Therapeutics shares.

MRSN Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockMersana Therapeutics82.62%1.51%15.87%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Nextech invest12.07M9.83%$17.26M
Ecor1 capital11.33M9.23%$16.20M
Vr adviser10.26M8.36%$14.67M
Blackrock funding, inc. /de9.21M7.50%$13.16M
Bain capital life sciences investors8.66M7.06%$12.39M
Blackrock8.38M6.90%$16.85M
Vanguard group7.06M5.75%$10.09M
Novo4.25M3.46%$6.08M
Rock springs capital management lp3.43M2.80%$4.91M
State street2.68M2.21%$5.39M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Nextech invest12.07M2.80%$17.26M
Acuta capital partners1.12M1.61%$1.60B
Bain capital life sciences investors8.66M1.46%$12.39M
Vr adviser10.26M1.01%$14.67M
Ecor1 capital11.33M0.61%$16.20M
5am venture management1.30M0.45%$1.87M
Novo4.25M0.37%$6.08M
Healthinvest partners ab538.62K0.36%$764.84K
Octagon capital advisors lp992.00K0.23%$1.42M
Exome asset management172.92K0.19%$249.72K

Top Buyers

HolderShares% AssetsChange
Novo4.25M0.37%4.25M
683 capital management900.00K0.08%717.21K
Sphera funds management690.27K0.18%690.27K
Blackrock funding, inc. /de9.21M0.00%583.32K
Millennium management795.97K0.00%536.19K

Top Sellers

HolderShares% AssetsChange
Ecor1 capital11.33M0.61%-8.04M
State street2.68M0.00%-2.82M
Cormorant asset management, lp---2.60M
Silverarc capital management---1.59M
Goldman sachs group802.37K0.00%-1.16M

New Positions

HolderShares% AssetsChangeValue
Novo4.25M0.37%4.25M$6.08M
Sphera funds management690.27K0.18%690.27K$987.09K
Mackenzie financial91.96K0.00%91.96K$129.69K
Susquehanna fundamental investments91.85K0.00%91.85K$131.35K
Sei investments69.53K0.00%69.53K$99.42K

Sold Out

HolderChange
Capital performance advisors llp-11.00
Nelson, van denburg & campbell wealth management group-22.00
Jones financial companies lllp-200.00
Nordwand advisors-1.50K
Pacer advisors-1.72K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 20241307.44%101,397,402-12.65%820.92%5813.73%3921.88%
Sep 30, 2024121-3.20%116,077,3431.64%941.07%52-17.46%32-11.11%
Jun 30, 2024125-2.34%114,205,327-2.80%940.99%63-12.50%36-
Mar 31, 202412817.43%117,492,7653.79%971.10%7241.18%362.86%
Dec 31, 2023109-18.05%113,199,475-0.47%930.97%51-16.39%35-20.45%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF3.47M2.78%-
Vanguard Total Stock Mkt Idx Inv3.47M2.78%-
iShares Russell 2000 ETF2.49M2.00%-21.61K
Vanguard Institutional Extnd Mkt Idx Tr1.52M1.22%-
Fidelity Small Cap Index1.14M0.91%-21.33K
State St Russell Sm/Mid Cp® Indx SL Cl I839.38K0.67%-
State St Russell Sm/Mid Cp® Indx NL Cl C839.38K0.67%-
Vanguard Explorer Inv614.97K0.50%-
HealthInvest Sustainable Healthcare E538.62K0.44%-
iShares Russell 2000 Growth ETF523.40K0.42%-2.49K

Recent Insider Transactions


DateNameRoleActivityValue
Jan 16, 2025Mandelia Ashish VP, Chief Accounting OfficerSell$2.06K
Jan 16, 2025Protopapas Anna-Sell$5.01K
Jan 16, 2025Lowinger Timothy B SVP, Chief Sci.&Tech. OfficerSell$4.67K
Jan 16, 2025Huber Martin H. Jr. President, CEOSell$2.62K
Jan 16, 2025DeSchuytner Brian SVP, COO & CFOSell$4.91K

Insider Transactions Trends


DateBuySell
2025 Q1-18
2024 Q4-11
2024 Q3-1
2024 Q2--
2024 Q1-7

MRSN Ownership FAQ


Who Owns Mersana Therapeutics?

Mersana Therapeutics shareholders are primarily institutional investors at 82.62%, followed by 1.51% insiders and 15.87% retail investors. The average institutional ownership in Mersana Therapeutics's industry, Biotech Stocks , is 68.48%, which Mersana Therapeutics exceeds.

Who owns the most shares of Mersana Therapeutics?

Mersana Therapeutics’s largest shareholders are Nextech invest (12.07M shares, 9.83%), Ecor1 capital (11.33M shares, 9.23%), and Vr adviser (10.26M shares, 8.36%). Together, they hold 27.42% of Mersana Therapeutics’s total shares outstanding.

Does Blackrock own Mersana Therapeutics?

Yes, BlackRock owns 6.90% of Mersana Therapeutics, totaling 8.38M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 16.85M$. In the last quarter, BlackRock increased its holdings by 288.18K shares, a 3.56% change.

Who is Mersana Therapeutics’s biggest shareholder by percentage of total assets invested?

Nextech invest is Mersana Therapeutics’s biggest shareholder by percentage of total assets invested, with 2.80% of its assets in 12.07M Mersana Therapeutics shares, valued at 17.26M$.

Who is the top mutual fund holder of Mersana Therapeutics shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Mersana Therapeutics shares, with 2.78% of its total shares outstanding invested in 3.47M Mersana Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools